Locally advanced Thyroid Cancer, Anaplastic

Also known as: Locally advanced Anaplastic Thyroid Cancer

DrugDrug NameDrug Description
DB08912DabrafenibA kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
DB08911TrametinibA kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer.
DrugDrug NamePhaseStatusCount